Delivery Order SPE2DR25D1103-SPE2DR26FE081
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,471.51 delivery order (Contract No. 4570186679) to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The non-competitive delivery order, issued on December 5, 2025, with completion by December 8, 2025, represents a firm fixed-price transaction under a child contract arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,991.67 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order is scheduled for completion by December 2, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the open market. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,061.39 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, awarded on October 27, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,507.05 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and represents a single transaction for pharmaceutical supply to support federal medical needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $3,901.00 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with completion targeted for December 5, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the location of performance—is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,043.61 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order, awarded on October 23, 2025, with no set-aside designation, represents a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors valued at $2,902.67, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,001.46 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of November 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $36,129.49 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on November 14, 2025, with an ultimate completion date of November 17, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $22,521.04 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle with DLA. This delivery order falls under...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE081Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,461.62 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. The contract, which became effective on November 25, 2025, with completion scheduled for November 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, drawing from its substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 and extending through December 2026. This delivery order falls under AmerisourceBergen Drug Corp's broader pharmaceutical supply agreement with the DLA, which enables the company to distribute a comprehensive range of medications and medical supplies to support military healthcare systems. Repatha (evolocumab) is a PCSK9 inhibitor used for cholesterol management and cardiovascular disease prevention, representing the specialized pharmaceutical products that constitute a significant portion of DLA's medical procurement activities. The award reflects AmerisourceBergen's established capability as a critical vendor for federal medical supply needs through open, competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/24/25 |